Vaccines and Related Biological Products Advisory Committee
September 14-15, 1999 Meeting
Date and Time
The meeting will be held on September 14, 1999 from 1:00 to 5:00 pm and on September 15, 1999 from 8:00 am to 4:00 pm.
Location
Holiday Inn, Versailles Ballrooms I and II, 8120 Wisconsin Avenue, Bethesda, MD 20814, 301-652-2000.
Contact Person
Nancy T. Cherry or Denise H. Royster, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138
(301-443-0572 in the Washington, DC area) code 12391. Please call the Information line for up-to-date
information on this meeting.
Oral Presentations
Oral presentations from the public will be scheduled on September 14, 1999 between approximately 2:10 to 2:50 pm and on September 15, 1999 between approximately 12:10 to 12:30 pm. Those desiring to make formal oral presentations should notify the contact person before September 7, 1999.
Agenda
On September 14, 1999 the committee will hear reports on recent workshops on Thimerosal in Vaccines and Cell Substrates
for Vaccine Development and be updated on recent developments concerning the rotavirus vaccine manufactured by Wyeth
Laboratories, Inc. The committee will also be briefed on selected individual research programs in the Laboratory of
Parasitic Biology and the Laboratory of Biophysics. On September 15, 1999 the committee will discuss the use of
immunologic surrogates for demonstration of protective efficacy of meningococcal conjugate vaccines.
Closed Committee Deliberations
On September 14, 1999 from 3:10 to 4:00 pm the meeting will be closed to permit discussion and review of trade secret
and/or confidential information. (5 U.S.C. 552b (c) (4)). Also, on September 14, 1999 from 4:00 to 5:00 pm the meeting
will be closed to permit discussion where disclosure would constitute a clearly unwarranted invasion of personal
privacy (5 U.S.C. 552b (c) (6)).
|
